A disproportionate contribution of papillary muscles and trabeculations to total left ventricular mass makes choice of cardiovascular magnetic resonance analysis technique critical in Fabry disease

Journal of Cardiovascular Magnetic Resonance

Volumn 17, Issue 1, 2015, Pages

  Kozor, Rebecca ^a,b   Callaghan, Fraser ^c   Tchan, Michel ^c,d   Hamilton Craig, Christian ^e,f   Figtree, Gemma A ^a,b   Grieve, Stuart M ^a,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d WESTMEAD HOSPITAL   (Australia)

^e THE PRINCE CHARLES HOSPITAL   (Australia)

^f UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Cardiovascular magnetic resonance imaging; Fabry disease; Left ventricular hypertrophy; Papillary muscles

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FABRY DISEASE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE VOLUME; HEART PAPILLARY MUSCLE; HUMAN; MALE; PRIORITY JOURNAL; CASE CONTROL STUDY; CINE MAGNETIC RESONANCE IMAGING; COMPARATIVE STUDY; COMPUTER ASSISTED DIAGNOSIS; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; HEART VENTRICLE; HYPERTROPHY, LEFT VENTRICULAR; MIDDLE AGED; OBSERVER VARIATION; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; PROGNOSIS; REGISTER; REPRODUCIBILITY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; FABRY DISEASE; HEART VENTRICLES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; OBSERVER VARIATION; PAPILLARY MUSCLES; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REGISTRIES; REPRODUCIBILITY OF RESULTS; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT; YOUNG ADULT;

EID: 84924084307     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/s12968-015-0114-4     Document Type: Article

References (21)

1. Zarate YA, Hopkin RJ. Fabry's disease. Lancet. 2008;372:1427-35.
2. Patel MR, Cecchi F, Cizmarik M, Kantola I, Linhart A, Nicholls K, et al. Cardiovascular events in patients with fabry disease natural history data from the fabry registry. Journal of the American College of Cardiology. 2011;57:1093-9.
3. Weinsaft JW, Cham MD, Janik M, Min JK, Henschke CI, Yankelevitz DF, et al. Left ventricular papillary muscles and trabeculae are significant determinants of cardiac MRI volumetric measurements: effects on clinical standards in patients with advanced systolic dysfunction. Int J Cardiol. 2008;126:359-65.
4. Sievers B, Kirchberg S, Bakan A, Franken U, Trappe HJ. Impact of papillary muscles in ventricular volume and ejection fraction assessment by cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2004;6:9-16.
5. Janik M, Cham MD, Ross MI, Wang Y, Codella N, Min JK, et al. Effects of papillary muscles and trabeculae on left ventricular quantification: increased impact of methodological variability in patients with left ventricular hypertrophy. J Hypertens. 2008;26:1677-85.
6. Papavassiliu T, Kuhl HP, Schroder M, Suselbeck T, Bondarenko O, Bohm CK, et al. Effect of endocardial trabeculae on left ventricular measurements and measurement reproducibility at cardiovascular MR imaging. Radiology. 2005;236:57-64.
7. Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E. Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols. J Cardiovasc Magn Reson. 2008;10:35.
8. Rosset A, Spadola L, Ratib O, Osiri X. An open-source software for navigating in multidimensional DICOM images. Journal of digital imaging : the official journal of the Society for Computer Applications in Radiology. 2004;17:205-16.
9. Childs H, Ma L, Ma M, Clarke J, Cocker M, Green J, et al. Comparison of long and short axis quantification of left ventricular volume parameters by cardiovascular magnetic resonance, with ex-vivo validation. J Cardiovasc Magn Reson. 2011;13:40.
10. Lotz J, Meier C, Leppert A, Galanski M. Cardiovascular flow measurement with phase-contrast MR imaging: basic facts and implementation. Radiographics. 2002;22:651-71.
11. Gelfand EV, Hughes S, Hauser TH, Yeon SB, Goepfert L, Kissinger KV, et al. Severity of mitral and aortic regurgitation as assessed by cardiovascular magnetic resonance: optimizing correlation with Doppler echocardiography. J Cardiovasc Magn Reson. 2006;8:503-7.
12. Chuang ML, Gona P, Hautvast GL, Salton CJ, Blease SJ, Yeon SB, et al. Correlation of trabeculae and papillary muscles with clinical and cardiac characteristics and impact on CMR measures of LV anatomy and function. JACC Cardiovasc Imaging. 2012;5:1115-23.
13. van der Geest RJ, Buller VG, Jansen E, Lamb HJ, Baur LH, van der Wall EE, et al. Comparison between manual and semiautomated analysis of left ventricular volume parameters from short-axis MR images. J Comput Assist Tomogr. 1997;21:756-65.
14. Whybra C, Kampmann C, Krummenauer F, Ries M, Mengel E, Miebach E, et al. The Mainz Severity Score Index: a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy. Clin Genet. 2004;65:299-307.
15. Maceira A, Prasad S, Khan M, Pennell D. Normalized Left Ventricular Systolic and Diastolic Function by Steady State Free Precession Cardiovascular Magnetic Resonance. Journal of Cardiovascular Magnetic Resonance. 2006;8:417-26.
16. Niemann M, Herrmann S, Hu K, Breunig F, Strotmann J, Beer M, et al. Differences in Fabry cardiomyopathy between female and male patients: consequences for diagnostic assessment. JACC Cardiovasc Imaging. 2011;4:592-601.
17. Mehta A, Beck M, Eyskens F, Feliciani C, Kantola I, Ramaswami U, et al. Fabry disease: a review of current management strategies. QJM : monthly journal of the Association of Physicians. 2010;103:641-59.
18. Weidemann F, Niemann M, Breunig F, Herrmann S, Beer M, Störk S, et al. Long-term effects of enzyme replacement therapy on fabry cardiomyopathy: evidence for a better outcome with early treatment. Circulation. 2009;119:524-9.
19. Weidemann F, Breunig F, Beer M, Sandstede J, Turschner O, Voelker W, et al. Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: a prospective strain rate imaging study. Circulation. 2003;108:1299-301.
20. Imbriaco M, Pisani A, Spinelli L, Cuocolo A, Messalli G, Capuano E, et al. Effects of enzyme-replacement therapy in patients with Anderson-Fabry disease: a prospective long-term cardiac magnetic resonance imaging study. Heart (British Cardiac Society). 2009;95:1103-7.
21. Da H, Elliott PM, Shah J, Zuckerman J, Coghlan G, Brookes J, et al. Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa. Heart (British Cardiac Society). 2008;94:153-8.